food allergies

Alladapt's 15-allergen drug desensitizes kids to multiple foods, teeing up pivotal program
Alladapt's 15-allergen drug desensitizes kids to multiple foods, teeing up pivotal program
Fierce Biotech
Alladapt Immunotherapeutics
clinical trials
allergies
food allergies
ADP101
Flag link:
Nestlé wagers $41M on Enterome's preclinical food allergy and IBD prospect
Nestlé wagers $41M on Enterome's preclinical food allergy and IBD prospect
Fierce Biotech
Nestle
Enterome
food allergies
IBD
Flag link:
Appetite for allergies: Alladapt banks $119M to push immunotherapy through trials
Appetite for allergies: Alladapt banks $119M to push immunotherapy through trials
Fierce Biotech
Alladapt Immunotherapeutics
funding
FDA
food allergies
immunotherapy
Flag link:
Aimmune Becomes Point Pharmaceutical Business for Nestlé
Aimmune Becomes Point Pharmaceutical Business for Nestlé
BioSpace
Nestle
Aimmune
M&A
food allergies
Flag link:
Mount Sinai and AllerGenis Partner to Develop Novel, Precision Diagnostics For Food Allergy Testing Configure
Mount Sinai and AllerGenis Partner to Develop Novel, Precision Diagnostics For Food Allergy Testing Configure
CP Wire
AllerGenis
food allergies
diagnostics
Flag link:
Mount Sinai and AllerGenis Partner to Develop Novel, Precision Diagnostics For Food Allergy Testing
AllerGenis
food allergies
Flag link:
Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies
Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies
Fierce Pharma
Novartis
Roche
Xolair
FDA
food allergies
Flag link:
DBV climbs as messy milk allergy data open door to phase 3
DBV climbs as messy milk allergy data open door to phase 3
Fierce Biotech
DBV Technologies
food allergies
milk allergy
Viaskin Milk
Flag link:
Peanut allergy therapy scores trial win, putting it in line to possibly become first protective treatment
Peanut allergy therapy scores trial win, putting it in line to possibly become first protective treatment
Stat
peanut allergy
food allergies
clinical trials
AR101
Aimmune
Flag link:
A new peanut allergy vaccine failed in a trial, but the company wants it approved anyway
A new peanut allergy vaccine failed in a trial, but the company wants it approved anyway
Stat
vaccines
food allergies
peanut allergy
DBV Technologies
Viaskin Peanut
Flag link:
Regeneron-Sanofi food allergy drug succeeds mid-stage study
Regeneron-Sanofi food allergy drug succeeds mid-stage study
Yahoo/Reuters
Regeneron
Amgen
food allergies
eosinophilic esophagitis
Dupixent
Flag link:
Biotech Billionaire Backs Company Geared At Ending Food Allergies
Biotech Billionaire Backs Company Geared At Ending Food Allergies
Forbes
food allergies
Ernesto Bertarelli
Flag link:
Aimmune plots a $153M IPO to fund its 'breakthrough' food allergy pill
Aimmune plots a $153M IPO to fund its 'breakthrough' food allergy pill
Fierce Biotech
IPOs
Aimmune
food allergies
peanut allergy
Flag link:
DBV makes a beeline for Phase III as peanut allergy race hots up
DBV makes a beeline for Phase III as peanut allergy race hots up
Fierce Biotech
DBV Technologies
vaccines
food allergies
peanut allergy
Viaskin Peanut
Flag link:
Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy
Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy
Yahoo
GLAAS plantform
Immune Design
Sanofi
food allergies
Flag link:
Food allergy startup bags $17M for oral immunotherapy
Food allergy startup bags $17M for oral immunotherapy
Fierce Biotech
food allergies
Allergen Research Corp
Flag link: